Skip to content

Geron GERN Net margin

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
15%+3.8pp
Incyte logo
IncyteINCY
26.7%+26.2pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-111.9%-51.5pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-156.4%-47.5pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-188.2%-55.4pp

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-7.6%
Enterprise value$973.78M-5.3%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Calculated from Geron’s reported figures.

Based on trailing twelve months.

The official record: Geron’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Geron's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's net margin?
Geron (GERN) reported net margin of -682.5% in Q3 2024.
How has Geron's net margin changed year-over-year?
Geron's net margin increased by 98.8% year-over-year, from -55,138.5% to -682.5%.
What is the long-term trend for Geron's net margin?
Over 3 years (2020 to 2023), Geron's net margin has grown at a 37.5% compound annual growth rate (CAGR), from -29,888.1% to -77,690.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.